000 01281cam a2200433 a 4500
001 3510202
003 BD-DhUL
005 20150205171057.0
008 840201s1984 dcua b f001 0 eng c
010 _a 84601000
016 7 _a8405259
_2DNLM
020 _a0912257016
020 _a0444995862
029 1 _aNLM
_b8405259
035 _a(OCoLC)ocm10380434
035 _a(NNC)3510202
037 _a052-003-00939-1
_bGPO
040 _aDGPO/DLC
_cDLC
_dWQM
_dNLM
_dGPO
_dMvI
_dMvI
_dBD-DhUL
043 _an-us---
050 0 0 _aHD9999.B443
_bU618 1984
060 0 _aDD1771
070 _aHD9999.B443U618
074 _a1070-M
074 _a1070-M (online)
082 0 0 _a574
_219
_bCOM
086 0 _aY 3.T 22/2:2 C 73/7
110 2 _aElsevier Science Publishers
245 0 0 _aCommercial biotechnology :
_ban international analysis /
_cElsevier Science Publishers.
260 _aAmsterdam :
_bElsevier,
_c1984.
300 _avii, 612 p. :
_bill. ;
_c26 cm.
365 _aUS$
_b395.00
504 _aIncludes bibliographical references and index.
650 0 _aBiotechnology industries
_zUnited States.
650 0 _aBiotechnology industries.
650 0 _aCompetition, International.
650 2 _aBiological Factors.
650 2 _aTechnology.
942 _2ddc
_cBK
999 _c19614
_d19614